Access cutting-edge leukemia treatment through this phase 1 clinical trial at a research site in Memphis. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Memphis location
Preparing your pre-screening questions…
Access leukemia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related leukemia treatment provided free
Check if you qualify for this leukemia clinical trial in Memphis, TN
No-Cost Study Care
Local to Memphis
Convenient for TN residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a single-arm pilot clinical trial evaluating dalbavancin-based prophylaxis in children and adolescents with acute myeloid leukemia or relapsed lymphoblastic leukemia receiving myelosuppressive chemotherapy. Primary objective: \- To estimate the rate of bacterial bloodstream infection in pediatric patients with AML or relapsed ALL undergoing chemotherapy receiving dalbavancin-based prophylaxis Secondary objectives: * To describe the population pharmacokinetics of every 28 days dalbavancin up to 12 weeks in pediatric patients with AML or relapsed ALL undergoing chemotherapy * To describe the tolerability of every 28 days dalbavancin prophylaxis in pediatric patients with AML or relapsed ALL undergoing chemotherapy * To describe the acceptability of every 28 days dalbavancin prophylaxis in pediatric patients with AML or relapsed ALL undergoing chemotherapy * To estimate the rates of likely bacterial infections, Clostridioides difficile infection, and febrile neutropenia in pediatric patients receiving dalbavancin-based prophylaxis
Sponsor: St. Jude Children's Research Hospital
Yes, this clinical trial (NCT06810583) has an active research site in Memphis, TN that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for leukemia treatment options in Memphis, TN, this clinical trial (NCT06810583) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Memphis research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all leukemia clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Memphis — not just this study.
Browse Leukemia Trials in Memphis →